Yi Du Selected Research

MicroRNAs (MicroRNA)

1/2021	Propofol modulates the proliferation, invasion and migration of bladder cancer cells through the miR‑145‑5p/TOP2A axis.
4/2014	Increased microRNA-155 and decreased microRNA-146a may promote ocular inflammation and proliferation in Graves' ophthalmopathy.
5/2013	EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi Du Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 02/2007
7	Inflammation (Inflammations) 06/2022 - 04/2018
6	Pain (Aches) 01/2022 - 11/2009
5	Periodontitis 01/2020 - 01/2015
5	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2007
4	Carcinogenesis 05/2022 - 02/2010
4	Optic Neuritis (Retrobulbar Neuritis) 01/2022 - 04/2009
4	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 02/2013
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2020
3	COVID-19 05/2021 - 01/2020
3	Cataract (Cataracts) 01/2021 - 05/2015
3	Postoperative Pain 01/2021 - 01/2012
3	Graves Ophthalmopathy 01/2019 - 04/2014
2	Wounds and Injuries (Trauma) 06/2022 - 05/2022
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2022 - 01/2021
2	AIDS-Related Complex (ARC) 01/2022 - 03/2020
2	Heart Failure 04/2021 - 08/2011
2	Flatulence 01/2021 - 07/2020
2	Astigmatism 01/2021 - 01/2012
2	Stable Angina 01/2020 - 10/2014
2	Squamous Cell Carcinoma of Head and Neck 01/2020 - 01/2019
2	Pulpitis 12/2019 - 07/2015
2	Ischemia 11/2019 - 01/2013
2	Myopia 03/2019 - 01/2012
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 02/2016 - 07/2009
2	Hypoxia (Hypoxemia) 01/2015 - 05/2013
2	Disease Progression 01/2015 - 02/2007
2	Lung Neoplasms (Lung Cancer) 02/2013 - 08/2011
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 09/2022
1	Glomerulonephritis 06/2022
1	Impacted Tooth (Teeth, Impacted) 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Hyperalgesia 01/2022
1	Atrophy 01/2022
1	Hemorrhage 01/2022
1	Cysts 01/2022
1	Muscular Atrophy (Muscle Atrophy) 01/2022
1	Cystic Fibrosis (Mucoviscidosis) 05/2021
1	Acute Kidney Injury (Acute Renal Failure) 04/2021

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 06/2022 - 10/2005
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 02/2007
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019 - 02/2016
3	Pharmaceutical PreparationsIBA 09/2022 - 01/2020
3	NF-kappa B (NF-kB)IBA 06/2022 - 10/2009
3	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 02/2016
3	Butyrates (Butyrate)IBA 01/2022 - 01/2020
3	LigandsIBA 01/2022 - 01/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 04/2009
3	MicroRNAs (MicroRNA)IBA 01/2021 - 05/2013
3	mesoglycanIBA 01/2021 - 03/2019
3	Biological ProductsIBA 01/2020 - 12/2017
3	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2019 - 08/2011
3	Bevacizumab (Avastin)FDA Link 03/2019 - 08/2011
3	Messenger RNA (mRNA)IBA 01/2019 - 01/2015
3	Phosphotransferases (Kinase)IBA 01/2012 - 02/2007
2	CytokinesIBA 01/2022 - 01/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
2	LipopolysaccharidesIBA 01/2022 - 12/2019
2	Reserpine (Serpasil)FDA Link 01/2022 - 12/2019
2	Hemoglobins (Hemoglobin)IBA 04/2021 - 11/2015
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 10/2020
2	Substance PIBA 01/2021 - 01/2020
2	AlbuminsIBA 12/2020 - 10/2005
2	Heparin (Liquaemin)FDA LinkGeneric 06/2020 - 01/2020
2	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2020 - 10/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 03/2013
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 07/2009
2	uracil phosphoribosyltransferaseIBA 01/2017 - 08/2011
2	EndostatinsIBA 01/2017 - 08/2011
2	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 08/2011
2	Flucytosine (Ancobon)FDA Link 01/2017 - 08/2011
2	Neuroprotective AgentsIBA 01/2017 - 05/2014
2	Cytosine DeaminaseIBA 01/2017 - 08/2011
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 01/2015
1	Rabeprazole (Aciphex)FDA Link 09/2022
1	Azacitidine (5 Azacytidine)FDA Link 06/2022
1	MethyltransferasesIBA 06/2022
1	ChromatinIBA 05/2022
1	platelet protein P47 (pleckstrin)IBA 05/2022
1	Hormones (Hormone)IBA 01/2022
1	Sucrose (Saccharose)IBA 01/2022
1	Muscle Proteins (Muscle Protein)IBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Serine Proteases (Serine Protease)IBA 05/2021
1	Leukocyte Elastase (Neutrophil Elastase)IBA 05/2021
1	Uric Acid (Urate)IBA 04/2021

Therapy/Procedure

14	Therapeutics 01/2022 - 06/2010
3	Drug Therapy (Chemotherapy) 01/2015 - 08/2011
2	Hysterectomy 02/2022 - 01/2021
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 04/2021 - 01/2020
2	Aftercare (After-Treatment) 01/2021 - 10/2005
2	Phacoemulsification 01/2021 - 05/2015
2	Ligation 01/2020 - 04/2018
2	Renal Dialysis (Hemodialysis) 11/2015 - 10/2005
1	Lymph Node Excision (Lymph Node Dissection) 02/2022
1	Prostheses and Implants (Prosthesis) 01/2022
1	Osteotomy 01/2022